NCT04194723招募中不适用
Phase II Clinical Study on the Safety and Efficacy of Antireflux Mucosectomy (ARMS) for Treatment of Gastroesophageal Reflux
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 30
- 试验地点
- 2
- 主要终点
- Improvement in Gastro Esophageal Reflux symptoms
研究概览
简要总结
This is a phase II clinical study to investigate the safety and efficacy of endoscopic antireflux mucosectomy (ARMS) for treatment of GERD.
详细描述
The objective of the study is to establish the clinical efficacy and safety of ARMS for treatment of GERD.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with typical symptoms of GERD with symptomatic response to PPI therapy for ≥ 3 months
- •Hill's grade II and III of the gastroesophageal junction
- •One of the following abnormalities in the objective assessment 3.
- •Excessive acid exposure at the distal esophagus evidenced by 24 hour pH tests using % total time pH < 4 and / or DeMeester score 3.
- •Endoscopic evidence of LA classes A,B,C or D esophagitis 3.
- •Defective LES assessed by HRM with resting pressure of < 6mmHg or total length of less than 4cm or abdominal length of less than 2cm
排除标准
- •Age > 70 yrs of < 18 yrs
- •Any type of Hiatus hernia
- •Patients with underlying malignancy
- •ASA above grade III
结局指标
主要结局
Improvement in Gastro Esophageal Reflux symptoms
时间窗: 3 months
GERD symptoms evidence by the improvement in the Gastroesophageal Reflux Quality of Life (QoL) of ≥50% compared to the baseline off Proton Pump Inhibitors (PPI) value 3 months after the procedure
次要结局
- 24 hour pH study post ARMS(3 and 12 months)
- High resolution Manometry(3 and 12 months)
- Technical Success(1 day)
- Gastroesophageal junction classified by Hill's classification(3 and 12 months)
研究者
Philip Wai Yan CHIU
Professor
Chinese University of Hong Kong
研究点 (2)
Loading locations...
相似试验
尚未招募
不适用
Anti-reflux Mucosal Ablation Therapy Randomized Sham Control Trial for Gastroesophageal Reflux DiseaseGastroesophageal Reflux DiseaseNCT06106100Far Eastern Memorial Hospital68
进行中（未招募）
2 期
Safety and Efficacy of APG-157 in Head and Neck CancerHead and Neck CancerSquamous Cell Carcinoma of Oral CavitySquamous Cell Carcinoma of the OropharynxNCT05312710Aveta Biomics, Inc.24
Unknown
不适用
ARMA for Postoperative GERD After Sleeve GastrectomyGastroesophageal RefluxNCT05259579Chinese University of Hong Kong15
已完成
2 期
A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerCarcinoma, Non-Small-Cell LungAdenocarcinomaNCT02875340ValiSeek Limited8
招募中
2 期
A Clinical Study of 9MW2821 (and PD-1 Inhibitor) in Locally Advanced or Metastatic Triple-Negative Breast CancerTriple-Negative Breast CancerNCT06492005Mabwell (Shanghai) Bioscience Co., Ltd.160